CDSCO bans injectable cosmetics, cites Drugs and Cosmetics Act violations
Synopsis
India's drug regulator has put aesthetic clinics and beauty professionals on notice: injecting cosmetic products is illegal under the Drugs and Cosmetics Act, 1940. The CDSCO's 19 May public notice closes a gap that a booming injectable-beauty industry had been quietly exploiting — and signals that enforcement, not just guidance, is now on the table.
Key Takeaways
The CDSCO issued a public notice on 19 May banning the use of cosmetic products via injection.
The ban covers consumers, professionals, and aesthetic clinics across India.
Injectable-form products do not qualify as cosmetics under the Drugs and Cosmetics Act, 1940 and Cosmetics Rules, 2020 .
Misleading labelling and tampering with manufacturer markings are also prohibited under the same notice.
Restricted and GNRAS ingredients are listed by the Bureau of Indian Standards (BIS) ; violations attract enforcement action.
The public has been asked to report violations to the CDSCO or respective state licensing authorities .
India's apex drug regulator, the Central Drugs Standard Control Organisation (CDSCO), issued a public notice on Tuesday, 19 May, declaring that no cosmetic product is permitted to be administered through injections — and warned that any such practice constitutes a direct violation of the Drugs and Cosmetics Act, 1940, and the Cosmetics Rules, 2020. The notice applies to consumers, professionals, and aesthetic clinics alike.
What the CDSCO Notice Says
The regulator drew a clear legal line: cosmetics are defined exclusively as products intended to be 'rubbed, poured, sprinkled or sprayed on, or introduced into, or otherwise applied to, the human body.' Products supplied in injectable form, the notice states, fall outside this definition entirely and cannot be marketed or used as cosmetics.
'No cosmetic is permitted to be used for injection by consumers, professionals or aesthetic clinics,' the notice stated. The CDSCO also confirmed that cosmetics are not permitted to be used for treatment purposes by any individual or professional.
Prohibited Practices and Misleading Claims
Beyond the injection ban, the CDSCO flagged two additional areas of concern. First, misleading labelling — the notice specified that 'no cosmetic may purport or claim to convey any idea which is false or misleading to the intending user.' Second, tampering: no person is permitted to alter, obliterate, or deface any inscription or mark placed by the manufacturer on a product's container, label, or wrapper.
The regulator also highlighted the use of prohibited or restricted ingredients, noting that the list of Generally Not Recognised as Safe (GNRAS) and restricted substances is published by the Bureau of Indian Standards (BIS). Violations on any of these counts attract enforcement action under the Drugs and Cosmetics Act and associated rules.
Why This Matters for Aesthetic Clinics
The notice arrives against the backdrop of a rapidly expanding aesthetic medicine and skin-care industry in India, where injectable treatments — including certain skin-brightening and anti-ageing formulations — have grown in popularity at clinics and salons. Notably, some products marketed as cosmetics have reportedly been administered via injection, a practice the CDSCO has now explicitly prohibited in writing.
This is not the first time the regulator has moved to tighten oversight of the cosmetics segment. The Cosmetics Rules, 2020 already introduced a more structured regulatory framework, replacing older provisions. The latest notice reinforces those boundaries with a direct public communication.
How to Report Violations
The CDSCO urged the public to report suspected violations — including the use of injectable cosmetics or products with prohibited ingredients — to the regulatory authority or to the respective state licensing authorities. The regulator did not specify penalties in the notice but indicated that all violations are actionable under existing law.
As aesthetic procedures continue to grow in popularity across Indian cities, the notice signals that the CDSCO intends to hold clinics and professionals to the same legal standards as manufacturers and retailers.
Point of View
But its real significance lies in what it reveals about enforcement gaps. Injectable 'cosmetics' — skin-brightening serums, glutathione drips, anti-ageing formulations — have been a grey-market staple at aesthetic clinics in Indian metros for years, often administered without medical oversight. The regulator has now closed the definitional loophole that allowed sellers to label these products as cosmetics to avoid drug-licensing requirements. The harder question is whether state licensing authorities have the capacity to act on public complaints at the scale the industry has reached. A notice without a follow-up inspection drive risks being symbolic rather than corrective.
NationPress
4 Jul 2026
Frequently Asked Questions
What has the CDSCO banned regarding cosmetic injections?
The CDSCO has prohibited the use of any cosmetic product through injection by consumers, professionals, or aesthetic clinics. Under the Drugs and Cosmetics Act, 1940, cosmetics are legally defined as products meant to be rubbed, poured, sprinkled, or sprayed on the body — injectable use falls outside this definition entirely.
Does this ban apply to aesthetic clinics and beauty professionals?
Yes. The 19 May CDSCO notice explicitly names consumers, professionals, and aesthetic clinics as covered parties. Cosmetics are also not permitted to be used for treatment purposes by any individual or professional, according to the notice.
What other violations does the CDSCO notice address?
Beyond the injection ban, the notice prohibits misleading claims on cosmetic labels and tampering with manufacturer markings on containers or wrappers. Use of prohibited or restricted ingredients — listed by the Bureau of Indian Standards — also attracts action under the Drugs and Cosmetics Act.
Where can consumers report violations of the cosmetics rules?
The CDSCO has urged the public to report suspected violations to the regulatory authority directly or to the respective state licensing authorities. The notice does not specify a dedicated helpline but points to existing regulatory channels.
What law governs cosmetic products in India?
Cosmetic products in India are regulated under the Drugs and Cosmetics Act, 1940, and the Cosmetics Rules, 2020. The Cosmetics Rules, 2020 updated the earlier regulatory framework and introduced more structured oversight of cosmetic manufacturing, labelling, and distribution.
